Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview

Author:

Stroppel Luisa12,Schultz-Fademrecht Torsten1,Cebulla Martin1,Blech Michaela1,Marhöfer Richard J.3,Selzer Paul M.23ORCID,Garidel Patrick1

Affiliation:

1. Innovation Unit, PDB-TIP, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach an der Riss, Germany

2. Interfaculty Institute of Biochemistry, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 34, 72076 Tübingen, Germany

3. Boehringer Ingelheim Animal Health, Binger Str. 173, 55216 Ingelheim am Rhein, Germany

Abstract

Biological drugs intended for multi-dose application require the presence of antimicrobial preservatives to avoid microbial growth. As the presence of certain preservatives has been reported to increase protein and peptide particle formation, it is essential to choose a preservative compatible with the active pharmaceutical ingredient in addition to its preservation function. Thus, this review describes the current status of the use of antimicrobial preservatives in biologic formulations considering (i) appropriate preservatives for protein and peptide formulations, (ii) their physico-chemical properties, (iii) their in-/compatibilities with other excipients or packaging material, and (iv) their interactions with the biological compound. Further, (v) we present an overview of licensed protein and peptide formulations.

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference172 articles.

1. Parenteral Protein Formulations: An Overview of Approved Products within the European Union;Gervasi;Eur. J. Pharm. Biopharm.,2018

2. Transparency Market Research (2015). Peptide Therapeutics Market—Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014–2020, Transparency Market Research.

3. Antimicrobial Preservative Use in Parenteral Products: Past and Present;Meyer;J. Pharm. Sci.,2007

4. (2021, August 31). Pharmacircle. Available online: https://www.pharmacircle.com/.

5. Development of a Multidose Formulation for a Humanized Monoclonal Antibody Using Experimental Design Techniques;Gupta;AAPS PharmSci,2003

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3